Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer therapy. It serves as a building block in medicinal chemistry due to its ability to mimic purine bases, enabling interactions with biological targets such as enzymes and receptors. Its structure supports the design of small molecule drugs with improved selectivity and binding affinity. Commonly employed in research settings for structure-activity relationship (SAR) studies to optimize drug candidates.